GLN-Apremilast 30 mg – DIN 02518910
GLN-Apremilast is Apremilast 30 mg (tablet), sold in Canada. It is used for psoriatic arthritis. It is supplied by Glenmark Pharmaceuticals Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Apremilast 30 mg
- Brand
- GLN-Apremilast
- Strength
- 30 mg
- Used for
- Psoriatic arthritis
- Form
- Tablet
- Manufacturer
- Glenmark Pharmaceuticals Canada Inc
- Drug class
- Phosphodiesterase 4 inhibitor
- Sold in
- Canada
- DIN
- 02518910
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Apremilast used for?
Apremilast is used for psoriatic arthritis.
- Medicine type
- Phosphodiesterase 4 inhibitor
Official uses from the US prescribing label
Psoriatic Arthritis
OTEZLA is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with active psoriatic arthritis.
OTEZLA XR is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 50 kg with active psoriatic arthritis.
Plaque Psoriasis
OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
OTEZLA is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
OTEZLA XR is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 50 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Oral Ulcers Associated with Behçet's Disease
OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with oral ulcers associated with Behçet's Disease.
From the FDA-approved label on DailyMed (published Sep 11, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02518910.
- It names GLN-Apremilast, Apremilast 30 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as GLN-Apremilast by Glenmark Pharmaceuticals Canada Inc..
In Canada: prescription only.
Ingredients
Active: Apremilast
Other Apremilast pills
- APR 10 Apremilast 10 mg Pink, diamond, 8 mm Used for psoriatic arthritis
- APR 20 Apremilast 20 mg Brown, diamond, 10 mm Used for psoriatic arthritis
- APR 30 Apremilast 30 mg White, diamond, 12 mm Used for psoriatic arthritis
- AP 30 Apremilast 30 mg Brown, oval Used for psoriatic arthritis
- 30 Apremilast 30 mg Pink, diamond Used for psoriatic arthritis
- APR 75 Apremilast 75 mg Pink, round, 12 mm Used for psoriatic arthritis
- No picture yet DIN 02434334 Apremilast 30 mg Otezla, Tablet, sold in Canada Used for psoriatic arthritis
- No picture yet DIN 02521733 Apremilast 30 mg PMS-Apremilast, Tablet, sold in Canada Used for psoriatic arthritis